Research ArticleNuclear Oncology
In Vivo Detection of Malignant Thymic Masses by Indiium-111-DTPA-D-Phe1-Octreotide Scintigranhy
Secondo Lastoria, Emilia Vergara, Giovannella Palmieri, Wanda Acampa, Paola Varrella, Corradina Caracò, Raffaele A. Bianco, Pietro Muto and Marco Salvatore
Journal of Nuclear Medicine April 1998, 39 (4) 634-639;
Secondo Lastoria
Emilia Vergara
Giovannella Palmieri
Wanda Acampa
Paola Varrella
Corradina Caracò
Raffaele A. Bianco
Pietro Muto
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
In Vivo Detection of Malignant Thymic Masses by Indiium-111-DTPA-D-Phe1-Octreotide Scintigranhy
Secondo Lastoria, Emilia Vergara, Giovannella Palmieri, Wanda Acampa, Paola Varrella, Corradina Caracò, Raffaele A. Bianco, Pietro Muto, Marco Salvatore
Journal of Nuclear Medicine Apr 1998, 39 (4) 634-639;
In Vivo Detection of Malignant Thymic Masses by Indiium-111-DTPA-D-Phe1-Octreotide Scintigranhy
Secondo Lastoria, Emilia Vergara, Giovannella Palmieri, Wanda Acampa, Paola Varrella, Corradina Caracò, Raffaele A. Bianco, Pietro Muto, Marco Salvatore
Journal of Nuclear Medicine Apr 1998, 39 (4) 634-639;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Thymic Malignancies: From Clinical Management to Targeted Therapies
- Thymoma: Benign Appearance, Malignant Potential
- Conditions Suggesting Lymphoma: CASE 2. Mediastinal Liposarcoma in a Patient With Previous Testicular Cancer
- Octreotide Alone or With Prednisone in Patients With Advanced Thymoma and Thymic Carcinoma: An Eastern Cooperative Oncology Group Phase II Trial